MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 72 filers reported holding MILLENDO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 9.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $0 | -100.0% | 323 | -98.6% | 0.00% | – |
Q4 2020 | $49,000 | +32.4% | 22,793 | 0.0% | 0.00% | – |
Q3 2020 | $37,000 | -14.0% | 22,793 | -6.6% | 0.00% | – |
Q2 2020 | $43,000 | -81.6% | 24,393 | -45.0% | 0.00% | -100.0% |
Q1 2020 | $234,000 | +77.3% | 44,336 | +127.2% | 0.00% | +100.0% |
Q4 2019 | $132,000 | – | 19,514 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,396,615 | $20,949,000 | 5.04% |
GREAT POINT PARTNERS LLC | 1,288,093 | $19,321,000 | 1.91% |
Bpifrance SA | 1,078,670 | $16,180,000 | 1.84% |
Prosight Management, LP | 270,762 | $4,061,000 | 1.78% |
NEA Management Company, LLC | 1,766,779 | $26,502,000 | 1.38% |
ADAMS STREET PARTNERS LLC | 459,146 | $6,543,000 | 1.27% |
Samsara BioCapital, LLC | 45,101 | $677,000 | 0.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,860 | $925,000 | 0.34% |
PA Capital LLC | 15,263 | $229,000 | 0.24% |
Fondren Management LP | 14,478 | $217,000 | 0.17% |